Human intestinal microbial metabolism of naringin
Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons’ fecal water, which have intestinal microbial enzyme, were u...
Saved in:
Published in | European journal of drug metabolism and pharmacokinetics Vol. 40; no. 3; pp. 363 - 367 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
01.09.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons’ fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person’s fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects’ fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons’ feces were used for incubation. In this second experiment, 15 persons’ feces could degrade 4-HPPA, but the other 7 subjects’ could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies. |
---|---|
AbstractList | Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies. Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies.Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study, human intestinal microbial metabolism of naringin was studied in vitro. Six persons' fecal water, which have intestinal microbial enzyme, were used in the first experiment. Naringin was metabolized by fecal water into naringenin. Subsequently, 3-(4-hydroxyphenyl)propionic acid (4-HPPA) was produced with naringenin degradation by a person's fecal water. However, 4-HPPA was not detected after naringenin degradation by the other 5 subjects' fecal water and the reason might be that the degrading velocity of 4-HPPA exceeded the producing velocity. To confirm the difference in degrading 4-HPPA among human feces, 22 healthy persons' feces were used for incubation. In this second experiment, 15 persons' feces could degrade 4-HPPA, but the other 7 subjects' could not. Human feces showed different ability of degrading 4-HPPA, and there are no gender differences. These results may be helpful for explaining findings in pharmacological and toxicological studies and are groundwork for clinical studies. |
Author | Su, Weiwei Zhang, Kejian Zou, Wei Chen, Si Liu, Menghua Luo, Yulong Wang, Sheng Nie, Yichu Cheng, Guohua |
Author_xml | – sequence: 1 givenname: Wei surname: Zou fullname: Zou, Wei organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 2 givenname: Yulong surname: Luo fullname: Luo, Yulong organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 3 givenname: Menghua surname: Liu fullname: Liu, Menghua organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 4 givenname: Si surname: Chen fullname: Chen, Si organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 5 givenname: Sheng surname: Wang fullname: Wang, Sheng organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 6 givenname: Yichu surname: Nie fullname: Nie, Yichu organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 7 givenname: Guohua surname: Cheng fullname: Cheng, Guohua organization: Pharmacy College, Jinan University – sequence: 8 givenname: Weiwei surname: Su fullname: Su, Weiwei email: lssswwhk@gmail.com organization: Guangzhou Quality R&D Center of Traditional Chinese Medicine, Guangdong Key Laboratory of Plant Resources, School of Life Science, Sun Yat-sen University – sequence: 9 givenname: Kejian surname: Zhang fullname: Zhang, Kejian email: zkj5566@sohu.com organization: School of Pharmaceutical Sciences, Sun Yat-Sen University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24935725$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMtKAzEUhoNUbK19ADfSpZvRXCa3pRRvUHCj65DJJJIyk6nJDNS3N8NUFy56IJwEvv-Q812CWeiCBeAawTsEIb9PiBAkCojKfCQpDmdggRHk-SXgDCwg4aLgkrE5WKW0g7mIkJSyCzDHpSSUY7oA6GVodVj70NvU-6CbdetN7Co_3myvq67xqV13bh109OHThytw7nST7OrYl-Dj6fF981Js355fNw_bwpQC9oWVJaUOIyeZsbWTQjCBHWGcGiZhpStIHZWGM4O04DXWmtWYUa0ry5zBNVmC22nuPnZfQ_6dan0ytml0sN2QFOJQCEkEJxm9OaJD1dpa7aNvdfxWv2tmAE1AXi2laN0fgqAabarJpso21WhTHXKG_8sY3-ved6GP2jcnk3hKpv2ozEa164aY3aYToR-iZ4h8 |
CitedBy_id | crossref_primary_10_1016_j_jpba_2018_08_039 crossref_primary_10_1007_s13318_016_0380_z crossref_primary_10_3390_molecules24234287 crossref_primary_10_1016_j_jafr_2023_100583 crossref_primary_10_1016_j_jnutbio_2019_108255 crossref_primary_10_2174_1389557519666191009162641 crossref_primary_10_1080_10520295_2017_1305499 crossref_primary_10_1039_C6FO01851C crossref_primary_10_3390_molecules23040895 crossref_primary_10_1016_j_jchromb_2019_121846 crossref_primary_10_1002_ptr_6641 crossref_primary_10_3390_antiox9100982 crossref_primary_10_1016_j_phrs_2020_105264 crossref_primary_10_1016_j_biopha_2019_109439 crossref_primary_10_1016_j_jchromb_2017_07_015 crossref_primary_10_3390_nu14183765 crossref_primary_10_1016_j_biopha_2018_09_092 crossref_primary_10_1080_10408398_2020_1746234 crossref_primary_10_3390_metabo15030146 crossref_primary_10_2903_j_efsa_2024_8747 crossref_primary_10_1016_j_scitotenv_2024_177073 crossref_primary_10_1021_acs_jafc_7b01486 crossref_primary_10_3390_molecules24040679 crossref_primary_10_1016_j_apt_2022_103627 crossref_primary_10_1002_fft2_25 crossref_primary_10_1016_S1875_5364_18_30088_8 crossref_primary_10_1007_s00210_024_03672_w crossref_primary_10_1016_j_fct_2017_11_057 crossref_primary_10_3389_fphar_2019_00034 crossref_primary_10_1007_s11596_024_2921_z crossref_primary_10_1021_acs_jafc_9b06494 |
Cites_doi | 10.1016/j.ejphar.2012.06.040 10.1007/s00203-004-0676-2 10.1042/bj1301161 10.1007/BF03216747 10.1002/bdd.1775 10.1128/AEM.71.10.6077-6085.2005 10.1007/BF02973933 10.1016/j.anaerobe.2005.11.002 10.1016/j.intimp.2011.05.022 10.1128/MMBR.65.4.523-569.2001 10.1089/jmf.2012.2251 10.1055/s-0030-1250117 10.1007/s002030050010 10.1006/bbrc.2001.5001 10.1055/s-0031-1299746 10.1124/dmd.32.4.387 10.1007/s00394-003-0397-3 10.1016/j.intimp.2012.04.019 10.1016/j.freeradbiomed.2003.09.022 10.1021/jf0108056 10.1159/000139228 10.1007/s11101-008-9095-3 10.1016/0891-5849(90)90045-K 10.1016/j.etap.2011.01.006 10.1248/cpb.49.1640 10.1093/jn/135.1.48 10.1093/jn/136.6.1477 10.1093/jn/131.10.2648 |
ContentType | Journal Article |
Copyright | Springer International Publishing Switzerland 2014 |
Copyright_xml | – notice: Springer International Publishing Switzerland 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s13318-014-0193-x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2107-0180 |
EndPage | 367 |
ExternalDocumentID | 24935725 10_1007_s13318_014_0193_x |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -EM .GJ 06D 0R~ 0VY 1N0 2.D 2JN 2KG 2VQ 30V 4.4 406 408 40D 53G 5GY 67N 96X AAAUJ AABHQ AACDK AAEWM AAIAL AAIKX AAJKR AANXM AANZL AARHV AARTL AASML AATNV AAWCG AAYIU AAYOK AAYQN AAYTO AAYZH AAZMS ABAKF ABDZT ABFTV ABHLI ABJNI ABJOX ABKCH ABKMS ABPLI ABQBU ABTKH ABTMW ABWHX ABXPI ACAOD ACBXY ACCOQ ACDTI ACGFS ACKNC ACMLO ACPIV ACZOJ ADFZG ADHHG ADHIR ADINQ ADKPE ADRFC ADURQ ADYPR ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETCA AEVLU AEXYK AEYRQ AFBBN AFLOW AFWTZ AFZKB AGAYW AGDGC AGJBK AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AJBLW AJRNO ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH ASPBG AVWKF AWSVR AXYYD AZFZN BBWZM BGNMA CSCUP DNIVK DPUIP DU5 EBLON EBS EIOEI EJD EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FLLZZ FNLPD FRRFC FSGXE GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HMJXF HRMNR HVGLF HZ~ ITM IWAJR J-C JBSCW JZLTJ KOV LLZTM M4Y NQJWS NU0 O9- P2P R9I RLLFE ROL RSV S1Z S27 S3A S3B SBL SBY SCLPG SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW T13 TSG U2A U9L UG4 UTJUX UZXMN VC2 VDBLX VFIZW W48 WK8 Z45 Z7U Z87 ~A9 ~JE AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c480t-e9455f21f96cedf988682f3675c690bab05f59c76c1a87d2aa6d265aabe6fc2d3 |
IEDL.DBID | U2A |
ISSN | 0378-7966 2107-0180 |
IngestDate | Fri Jul 11 04:46:28 EDT 2025 Thu Apr 03 07:02:03 EDT 2025 Thu Apr 24 22:57:18 EDT 2025 Tue Jul 01 04:04:08 EDT 2025 Fri Feb 21 02:35:50 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | 3-(4-Hydroxyphenyl)propionic acid Naringin Metabolism Human intestinal microbiota |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-e9455f21f96cedf988682f3675c690bab05f59c76c1a87d2aa6d265aabe6fc2d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24935725 |
PQID | 1708893873 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1708893873 pubmed_primary_24935725 crossref_primary_10_1007_s13318_014_0193_x crossref_citationtrail_10_1007_s13318_014_0193_x springer_journals_10_1007_s13318_014_0193_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-09-01 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: 2015-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cham |
PublicationPlace_xml | – name: Cham – name: France |
PublicationTitle | European journal of drug metabolism and pharmacokinetics |
PublicationTitleAbbrev | Eur J Drug Metab Pharmacokinet |
PublicationTitleAlternate | Eur J Drug Metab Pharmacokinet |
PublicationYear | 2015 |
Publisher | Springer International Publishing |
Publisher_xml | – name: Springer International Publishing |
References | Aura (CR1) 2008; 7 Herles, Braune, Blaut (CR10) 2004; 181 Kim, Jung, Sohng, Han, Kim, Han (CR11) 1998; 21 Lee, Jeong, Choi, Hyun, Oh, Kim, Kim, Han, Bok (CR12) 2001; 284 Liu, Wu, Nie, Chen, Su, Li (CR14) 2011; 11 Walle, Walle, Halushka (CR25) 2001; 131 Griffiths, Barrow (CR8) 1972; 130 Zou, Yang, Liu, Su (CR29) 2012; 62 Diaz, Ferrandez, Prieto, Garcia (CR6) 2001; 65 Clavel, Henderson, Alpert, Philippe, Rigottier-Gois, Dore, Blaut (CR4) 2005; 71 Nikolic, van Breemen (CR21) 2004; 32 Chen, Zheng, Jia, Ju (CR3) 1990; 9 Liu, Zou, Yang, Peng, Su (CR15) 2012; 33 Liu, Yang, Zou, Guan, Zheng, Lai, Fang, Cai, Su (CR13) 2011; 31 Luo, Zhang, Li, Nie, Wu, Shen, Su (CR16) 2012; 13 Martin, Marhuenda, Perez-Guerrero, Franco (CR17) 1994; 49 Wang, Meselhy, Li, Nakamura, Min, Qin, Hattori (CR27) 2001; 49 Aura, O’Leary, Williamson, Ojala, Bailey, Puupponen-Pimia, Nuutila, Oksman-Caldentey, Poutanen (CR2) 2002; 50 Rechner, Smith, Kuhnle, Gibson, Debnam, Srai, Moore, Rice-Evans (CR22) 2004; 36 CR9 Yu, Jang, Kang, Sung, Kim (CR28) 1997; 20 Walle, Browning, Steed, Reed, Walle (CR26) 2005; 135 Nie, Wu, Li, Luo, Long, Xie, Shen, Su (CR19) 2012; 15 Schneider, Blaut (CR24) 2000; 173 Gao, Li, Yang, Fang, Su (CR7) 2011; 77 Nemeth, Plumb, Berrin, Juge, Jacob, Naim, Williamson, Swallow, Kroon (CR18) 2003; 42 Schindler, Mentlein (CR23) 2006; 136 Nie, Wu, Li, Xie, Luo, Shen, Su (CR20) 2012; 690 Clavel, Borrmann, Braune, Dore, Blaut (CR5) 2006; 12 YL Luo (193_CR16) 2012; 13 K Nemeth (193_CR18) 2003; 42 E Diaz (193_CR6) 2001; 65 DH Kim (193_CR11) 1998; 21 CH Lee (193_CR12) 2001; 284 R Schindler (193_CR23) 2006; 136 YC Nie (193_CR20) 2012; 690 D Nikolic (193_CR21) 2004; 32 C Herles (193_CR10) 2004; 181 T Clavel (193_CR4) 2005; 71 T Walle (193_CR25) 2001; 131 MJ Martin (193_CR17) 1994; 49 M Liu (193_CR15) 2012; 33 LA Griffiths (193_CR8) 1972; 130 H Schneider (193_CR24) 2000; 173 YC Nie (193_CR19) 2012; 15 S Gao (193_CR7) 2011; 77 LQ Wang (193_CR27) 2001; 49 193_CR9 AM Aura (193_CR1) 2008; 7 KU Yu (193_CR28) 1997; 20 T Clavel (193_CR5) 2006; 12 AR Rechner (193_CR22) 2004; 36 YT Chen (193_CR3) 1990; 9 M Liu (193_CR13) 2011; 31 W Zou (193_CR29) 2012; 62 AM Aura (193_CR2) 2002; 50 Y Liu (193_CR14) 2011; 11 T Walle (193_CR26) 2005; 135 16765860 - Anaerobe. 2006 Jun;12(3):140-7 2170243 - Free Radic Biol Med. 1990;9(1):19-21 22766066 - Eur J Pharmacol. 2012 Sep 5;690(1-3):207-13 22374702 - Biopharm Drug Dispos. 2012 Apr;33(3):123-34 22985397 - J Med Food. 2012 Oct;15(10 ):894-900 20645246 - Planta Med. 2011 Jan;77(1):16-21 11767089 - Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1640-3 14744633 - Free Radic Biol Med. 2004 Jan 15;36(2):212-25 21787720 - Environ Toxicol Pharmacol. 2011 May;31(3):485-9 18982483 - Arch Pharm Res. 1997 Oct;20(5):420-4 9875509 - Arch Pharm Res. 1998 Feb;21(1):17-23 16204524 - Appl Environ Microbiol. 2005 Oct;71(10):6077-85 11879065 - J Agric Food Chem. 2002 Mar 13;50(6):1725-30 15127184 - Arch Microbiol. 2004 Jun;181(6):428-34 12594539 - Eur J Nutr. 2003 Jan;42(1):29-42 10648107 - Arch Microbiol. 2000 Jan;173(1):71-5 4656801 - Biochem J. 1972 Dec;130(4):1161-2 11396955 - Biochem Biophys Res Commun. 2001 Jun 15;284(3):681-8 16702307 - J Nutr. 2006 Jun;136(6):1477-82 15039291 - Drug Metab Dispos. 2004 Apr;32(4):387-97 22270844 - Arzneimittelforschung. 2012 Apr;62(4):181-6 11584085 - J Nutr. 2001 Oct;131(10):2648-52 22575871 - Int Immunopharmacol. 2012 Jul;13(3):301-7 7972328 - Pharmacology. 1994 Sep;49(3):144-50 21640201 - Int Immunopharmacol. 2011 Oct;11(10):1606-12 11729263 - Microbiol Mol Biol Rev. 2001 Dec;65(4):523-69, table of contents 15623831 - J Nutr. 2005 Jan;135(1):48-52 |
References_xml | – volume: 690 start-page: 207 issue: 1–3 year: 2012 end-page: 213 ident: CR20 article-title: Naringin attenuates EGF-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IkappaB-NF-kappaB signaling pathways publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2012.06.040 – volume: 181 start-page: 428 issue: 6 year: 2004 end-page: 434 ident: CR10 article-title: First bacterial chalcone isomerase isolated from ramulus publication-title: Arch Microbiol doi: 10.1007/s00203-004-0676-2 – volume: 130 start-page: 1161 issue: 4 year: 1972 end-page: 1162 ident: CR8 article-title: Metabolism of flavonoid compounds in germ-free rats publication-title: Biochem J doi: 10.1042/bj1301161 – volume: 135 start-page: 48 issue: 1 year: 2005 end-page: 52 ident: CR26 article-title: Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans publication-title: J Nutr – volume: 21 start-page: 17 issue: 1 year: 1998 end-page: 23 ident: CR11 article-title: Intestinal bacterial metabolism of flavonoids and its relation to some biological activities publication-title: Arch Pharm Res doi: 10.1007/BF03216747 – volume: 136 start-page: 1477 issue: 6 year: 2006 end-page: 1482 ident: CR23 article-title: Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells publication-title: J Nutr – volume: 33 start-page: 123 issue: 3 year: 2012 end-page: 134 ident: CR15 article-title: Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.1775 – volume: 71 start-page: 6077 issue: 10 year: 2005 end-page: 6085 ident: CR4 article-title: Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans publication-title: Appl Environ Microbiol doi: 10.1128/AEM.71.10.6077-6085.2005 – volume: 20 start-page: 420 issue: 5 year: 1997 end-page: 424 ident: CR28 article-title: Metabolism of saikosaponin c and naringin by human intestinal bacteria publication-title: Arch Pharm Res doi: 10.1007/BF02973933 – volume: 12 start-page: 140 issue: 3 year: 2006 end-page: 147 ident: CR5 article-title: Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans publication-title: Anaerobe doi: 10.1016/j.anaerobe.2005.11.002 – volume: 11 start-page: 1606 issue: 10 year: 2011 end-page: 1612 ident: CR14 article-title: Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NF-kappaB pathway publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.05.022 – volume: 65 start-page: 523 issue: 4 year: 2001 end-page: 569 ident: CR6 article-title: Biodegradation of aromatic compounds by publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.65.4.523-569.2001 – volume: 15 start-page: 894 issue: 10 year: 2012 end-page: 900 ident: CR19 article-title: Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats publication-title: J Med Food doi: 10.1089/jmf.2012.2251 – volume: 77 start-page: 16 issue: 1 year: 2011 end-page: 21 ident: CR7 article-title: Antitussive effect of naringin on experimentally induced cough in publication-title: Planta Med doi: 10.1055/s-0030-1250117 – volume: 173 start-page: 71 issue: 1 year: 2000 end-page: 75 ident: CR24 article-title: Anaerobic degradation of flavonoids by ramulus publication-title: Arch Microbiol doi: 10.1007/s002030050010 – volume: 131 start-page: 2648 issue: 10 year: 2001 end-page: 2652 ident: CR25 article-title: Carbon dioxide is the major metabolite of quercetin in humans publication-title: J Nutr – volume: 284 start-page: 681 issue: 3 year: 2001 end-page: 688 ident: CR12 article-title: Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.2001.5001 – volume: 62 start-page: 181 issue: 4 year: 2012 end-page: 186 ident: CR29 article-title: Tissue distribution study of naringin in rats by liquid chromatography-tandem mass spectrometry publication-title: Arzneimittelforschung doi: 10.1055/s-0031-1299746 – volume: 32 start-page: 387 issue: 4 year: 2004 end-page: 397 ident: CR21 article-title: New metabolic pathways for flavanones catalyzed by rat liver microsomes publication-title: Drug Metab Dispos doi: 10.1124/dmd.32.4.387 – volume: 42 start-page: 29 issue: 1 year: 2003 end-page: 42 ident: CR18 article-title: Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans publication-title: Eur J Nutr doi: 10.1007/s00394-003-0397-3 – volume: 13 start-page: 301 issue: 3 year: 2012 end-page: 307 ident: CR16 article-title: Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2012.04.019 – ident: CR9 – volume: 36 start-page: 212 issue: 2 year: 2004 end-page: 225 ident: CR22 article-title: Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2003.09.022 – volume: 50 start-page: 1725 issue: 6 year: 2002 end-page: 1730 ident: CR2 article-title: Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro publication-title: J Agric Food Chem doi: 10.1021/jf0108056 – volume: 49 start-page: 144 issue: 3 year: 1994 end-page: 150 ident: CR17 article-title: Antiulcer effect of naringin on gastric lesions induced by ethanol in rats publication-title: Pharmacology doi: 10.1159/000139228 – volume: 7 start-page: 407 year: 2008 end-page: 429 ident: CR1 article-title: Microbial metabolism of dietary phenolic compounds in the colon publication-title: Phytochem Rev doi: 10.1007/s11101-008-9095-3 – volume: 9 start-page: 19 issue: 1 year: 1990 end-page: 21 ident: CR3 article-title: Flavonoids as superoxide scavengers and antioxidants publication-title: Free Radic Biol Med doi: 10.1016/0891-5849(90)90045-K – volume: 31 start-page: 485 issue: 3 year: 2011 end-page: 489 ident: CR13 article-title: Toxicokinetics of naringin, a putative antitussive, after 184-day repeated oral administration in rats publication-title: Environ Toxicol Pharmacol doi: 10.1016/j.etap.2011.01.006 – volume: 49 start-page: 1640 issue: 12 year: 2001 end-page: 1643 ident: CR27 article-title: The heterocyclic ring fission and dehydroxylation of catechins and related compounds by sp. strain SDG-2, a human intestinal bacterium publication-title: Chem Pharm Bull (Tokyo) doi: 10.1248/cpb.49.1640 – volume: 20 start-page: 420 issue: 5 year: 1997 ident: 193_CR28 publication-title: Arch Pharm Res doi: 10.1007/BF02973933 – volume: 77 start-page: 16 issue: 1 year: 2011 ident: 193_CR7 publication-title: Planta Med doi: 10.1055/s-0030-1250117 – volume: 181 start-page: 428 issue: 6 year: 2004 ident: 193_CR10 publication-title: Arch Microbiol doi: 10.1007/s00203-004-0676-2 – volume: 49 start-page: 144 issue: 3 year: 1994 ident: 193_CR17 publication-title: Pharmacology doi: 10.1159/000139228 – volume: 135 start-page: 48 issue: 1 year: 2005 ident: 193_CR26 publication-title: J Nutr doi: 10.1093/jn/135.1.48 – volume: 13 start-page: 301 issue: 3 year: 2012 ident: 193_CR16 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2012.04.019 – volume: 21 start-page: 17 issue: 1 year: 1998 ident: 193_CR11 publication-title: Arch Pharm Res doi: 10.1007/BF03216747 – volume: 12 start-page: 140 issue: 3 year: 2006 ident: 193_CR5 publication-title: Anaerobe doi: 10.1016/j.anaerobe.2005.11.002 – volume: 136 start-page: 1477 issue: 6 year: 2006 ident: 193_CR23 publication-title: J Nutr doi: 10.1093/jn/136.6.1477 – ident: 193_CR9 – volume: 130 start-page: 1161 issue: 4 year: 1972 ident: 193_CR8 publication-title: Biochem J doi: 10.1042/bj1301161 – volume: 42 start-page: 29 issue: 1 year: 2003 ident: 193_CR18 publication-title: Eur J Nutr doi: 10.1007/s00394-003-0397-3 – volume: 49 start-page: 1640 issue: 12 year: 2001 ident: 193_CR27 publication-title: Chem Pharm Bull (Tokyo) doi: 10.1248/cpb.49.1640 – volume: 131 start-page: 2648 issue: 10 year: 2001 ident: 193_CR25 publication-title: J Nutr doi: 10.1093/jn/131.10.2648 – volume: 11 start-page: 1606 issue: 10 year: 2011 ident: 193_CR14 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2011.05.022 – volume: 33 start-page: 123 issue: 3 year: 2012 ident: 193_CR15 publication-title: Biopharm Drug Dispos doi: 10.1002/bdd.1775 – volume: 62 start-page: 181 issue: 4 year: 2012 ident: 193_CR29 publication-title: Arzneimittelforschung doi: 10.1055/s-0031-1299746 – volume: 71 start-page: 6077 issue: 10 year: 2005 ident: 193_CR4 publication-title: Appl Environ Microbiol doi: 10.1128/AEM.71.10.6077-6085.2005 – volume: 284 start-page: 681 issue: 3 year: 2001 ident: 193_CR12 publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.2001.5001 – volume: 690 start-page: 207 issue: 1–3 year: 2012 ident: 193_CR20 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2012.06.040 – volume: 31 start-page: 485 issue: 3 year: 2011 ident: 193_CR13 publication-title: Environ Toxicol Pharmacol doi: 10.1016/j.etap.2011.01.006 – volume: 15 start-page: 894 issue: 10 year: 2012 ident: 193_CR19 publication-title: J Med Food doi: 10.1089/jmf.2012.2251 – volume: 7 start-page: 407 year: 2008 ident: 193_CR1 publication-title: Phytochem Rev doi: 10.1007/s11101-008-9095-3 – volume: 32 start-page: 387 issue: 4 year: 2004 ident: 193_CR21 publication-title: Drug Metab Dispos doi: 10.1124/dmd.32.4.387 – volume: 173 start-page: 71 issue: 1 year: 2000 ident: 193_CR24 publication-title: Arch Microbiol doi: 10.1007/s002030050010 – volume: 9 start-page: 19 issue: 1 year: 1990 ident: 193_CR3 publication-title: Free Radic Biol Med doi: 10.1016/0891-5849(90)90045-K – volume: 36 start-page: 212 issue: 2 year: 2004 ident: 193_CR22 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2003.09.022 – volume: 50 start-page: 1725 issue: 6 year: 2002 ident: 193_CR2 publication-title: J Agric Food Chem doi: 10.1021/jf0108056 – volume: 65 start-page: 523 issue: 4 year: 2001 ident: 193_CR6 publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.65.4.523-569.2001 – reference: 22766066 - Eur J Pharmacol. 2012 Sep 5;690(1-3):207-13 – reference: 11729263 - Microbiol Mol Biol Rev. 2001 Dec;65(4):523-69, table of contents – reference: 22985397 - J Med Food. 2012 Oct;15(10 ):894-900 – reference: 22374702 - Biopharm Drug Dispos. 2012 Apr;33(3):123-34 – reference: 11584085 - J Nutr. 2001 Oct;131(10):2648-52 – reference: 10648107 - Arch Microbiol. 2000 Jan;173(1):71-5 – reference: 11396955 - Biochem Biophys Res Commun. 2001 Jun 15;284(3):681-8 – reference: 21787720 - Environ Toxicol Pharmacol. 2011 May;31(3):485-9 – reference: 15127184 - Arch Microbiol. 2004 Jun;181(6):428-34 – reference: 22575871 - Int Immunopharmacol. 2012 Jul;13(3):301-7 – reference: 11767089 - Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1640-3 – reference: 18982483 - Arch Pharm Res. 1997 Oct;20(5):420-4 – reference: 15039291 - Drug Metab Dispos. 2004 Apr;32(4):387-97 – reference: 2170243 - Free Radic Biol Med. 1990;9(1):19-21 – reference: 16204524 - Appl Environ Microbiol. 2005 Oct;71(10):6077-85 – reference: 16702307 - J Nutr. 2006 Jun;136(6):1477-82 – reference: 22270844 - Arzneimittelforschung. 2012 Apr;62(4):181-6 – reference: 9875509 - Arch Pharm Res. 1998 Feb;21(1):17-23 – reference: 16765860 - Anaerobe. 2006 Jun;12(3):140-7 – reference: 14744633 - Free Radic Biol Med. 2004 Jan 15;36(2):212-25 – reference: 7972328 - Pharmacology. 1994 Sep;49(3):144-50 – reference: 11879065 - J Agric Food Chem. 2002 Mar 13;50(6):1725-30 – reference: 12594539 - Eur J Nutr. 2003 Jan;42(1):29-42 – reference: 4656801 - Biochem J. 1972 Dec;130(4):1161-2 – reference: 20645246 - Planta Med. 2011 Jan;77(1):16-21 – reference: 21640201 - Int Immunopharmacol. 2011 Oct;11(10):1606-12 – reference: 15623831 - J Nutr. 2005 Jan;135(1):48-52 |
SSID | ssj0000389556 |
Score | 2.214663 |
Snippet | Naringin, a major flavonoid in citrus fruits, has been proved to be a promising antitussive candidate. It undertakes complicated metabolism. In this study,... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 363 |
SubjectTerms | Bacteria - metabolism Biomedical and Life Sciences Biomedicine Feces - chemistry Female Flavanones - metabolism Flavonoids - metabolism Human Physiology Humans Intestines - metabolism Intestines - microbiology Male Medical Biochemistry Pharmaceutical Sciences/Technology Pharmacology/Toxicology Pharmacy Phenylpropionates - metabolism Short Communication |
Title | Human intestinal microbial metabolism of naringin |
URI | https://link.springer.com/article/10.1007/s13318-014-0193-x https://www.ncbi.nlm.nih.gov/pubmed/24935725 https://www.proquest.com/docview/1708893873 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NS8MwFA-yXbyI386PUUF20BW6pGmS45DNoSA7bDBPJW0SGGyd2A7cf-9LP1ZkKnjrIU3Key_J79f38gtCd4CQBZVcuEqowPU1hnXQV74LJI4bwWBCFdUWr8Fo6j_P6Kw8x51W1e5VSjJfqevDbgTiD6ivrZoQxAXg2KSWukMQT3F_-2PFKsZRWuQogSExwPNVNvOnXr7vRzsgcydBmu87w0N0UAJGp194-Ajt6eQYdcaF4vSm60zqA1Rp1-k441qLenOCevlPeseKQsBcth0t57n0kn3SGUTAYp4unZVxEmnHnyenaDocTB5HbnlLghv73MtcLXxKDe4ZEcRaGcF5wLEhQARiYL6RjDxqqIhZEPckZwpLGSgcUCkjHZgYK3KGGskq0RfI4VxFQvqG6ZiD27AkDBOtwMkc-8ajLeRVtgrjUkLc3mSxCGvxY2veEMwbWvOGny10v33lvdDP-KvxbeWAEKLcpi5kolfrNOwxW45FOCMtdF54ZtsdEEhCGYave6hcFZYTMf19rMt_tb5C-4CUaFFcdo0a2cda3wAayaI2avaf3l4G7TwKvwCYftfS |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA5SD3oR39bnCtKDdqFNNpvkWMRStZYeWugtZDcJFNqtuC3Yf-9kHy1SFbztIZuEmUnyTWbmC0J3gJAFVVz4WujQDwyGfTDQgQ9OHLeCwYLKsy16YWcYvIzoqKjjTsts9zIkme3U62I3AvYHrq_LmhDEB-C4DViAuzyuIW6tLlYcYxyleYwSPCQGeL6MZv7Uy_fzaANkbgRIs3OnvY_2CsDotXINH6AtkxyiWj9nnF7WvcG6gCqtezWvv-aiXh6hZnZJ7zlSCFjLrqPpOKNecl9mDhYwGadTb2a9RLnxx8kxGrafBo8dv3glwY8D3pj7RgSUWty0IoyNtoLzkGNLwBGIwfONVNSgloqYhXFTcaaxUqHGIVUqMqGNsSYnqJLMEnOGPM51JFRgmYk5qA0rwjAxGpTMcWAbtIoapaxkXFCIu5csJnJNfuzEK0G80olXflbR_eqX95w_46_Gt6UCJFi5C12oxMwWqWwyl45FOCNVdJprZtUdOJCEMgyzeyhVJYuFmP4-1vm_Wt-gnc7grSu7z73XC7QLqInmiWaXqDL_WJgrQCbz6DqzxC8i-Nkx |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA6iIF7Et_W5gnjQLu4mm01yLGrxRenBQm8hu0mgULfibsH-eyf7aBEf4G0P2STMTJJvMjNfEDoHhCyo4sLXQsd-ZDDsg5GOfHDiuBUMFlSVbdGL7wfR45AO63dO8ybbvQlJVjUNjqUpK67ftL1eFL4RsEVwg10GhSA-gMgV2I1DZ9YD3Jlfsjj2OEqreCV4SwywfRPZ_KmXr2fTN8D5LVhankHdDbReg0evU2l7Ey2ZbAtd9Cv26Vnbe1kUU-Vt78LrL3ipZ9soLC_sPUcQAevadfQ6KmmY3JcpwBrGo_zVm1gvU278UbaDBt27l5t7v34xwU8jHhS-ERGlFodWxKnRVnAec2wJOAUpeMGJSgJqqUhZnIaKM42VijWOqVKJiW2KNdlFy9kkM_vI41wnQkWWmZSDCrEiDBOjQeEcRzagLRQ0spJpTSfuXrUYywURshOvBPFKJ1750UKX81_eKi6NvxqfNQqQYPEujKEyM5nmMmQuNYtwRlpor9LMvDtwJgllGGZ31ahK1osy_32sg3-1PkWr_duufH7oPR2iNQBQtMo5O0LLxfvUHANIKZKT0hA_AcsN3W0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+intestinal+microbial+metabolism+of+naringin&rft.jtitle=European+journal+of+drug+metabolism+and+pharmacokinetics&rft.au=Zou%2C+Wei&rft.au=Luo%2C+Yulong&rft.au=Liu%2C+Menghua&rft.au=Chen%2C+Si&rft.date=2015-09-01&rft.issn=0378-7966&rft.eissn=2107-0180&rft.volume=40&rft.issue=3&rft.spage=363&rft.epage=367&rft_id=info:doi/10.1007%2Fs13318-014-0193-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13318_014_0193_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-7966&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-7966&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-7966&client=summon |